Could This International ETF Be One of the Best Investments of 2026?

MSCI EAFE trades at roughly 15x earnings versus the S&P 500 at ~23x, and yields ~3.4% compared with ~1.5% for the S&P 500, signaling a valuation and income advantage for international stocks. Schwab International Equity ETF (SCHF) offers broad developed-ex‑US exposure (~1,500 holdings; top markets Japan, U.K., Canada, France), a rock‑bottom expense ratio of 0.03% and a ~3.2% dividend yield. Non‑U.S. stocks outperformed the S&P 500 by >10 percentage points in 2025 and are ahead so far in 2026. Principal risks include currency and geopolitical headwinds and lower exposure to the AI/US large‑cap tech trend.

Analysis

The international equity discount is not a single macro signal but a high-dispersion opportunity: exporters tied to cyclical capex and semiconductor supply chains (ASML and its suppliers) have idiosyncratic upside from re-shoring and non-China backlog reallocation, while large-cap European pharmas (AZN) offer steadier cash returns that benefit from yield-hunting flows. Conversely, the primary downside for broad international exposure is currency volatility and flow reversals — a short, sharp USD rally or renewed risk-off would compress local-currency returns even if underlying earnings recover.

Near-term catalysts are flow- and policy-driven rather than purely fundamental; central-bank divergence, quarterly index reconstitutions, and geopolitical shocks can flip relative performance inside weeks to months. Over multi-year horizons the key bear case is faster-than-expected adoption of AI and cloud platforms by US incumbents that extend their multiple premium, leaving international earnings growth unable to close the gap without genuine structural uplift.

The consensus treats broad international ETFs as a cheap passive fix — that understates the value of active factor tilts. A concentrated barbell (high-conviction cyclicals + defensive cash-flowers) with explicit FX overlay captures asymmetric upside: cyclicals re-rate if capex recovers while defensives protect income if multiple compression persists. Hedging and timing matter: entry windows are best after USD weakness and prior to major central-bank meetings when dispersion tends to widen.

Key Decisions for Investors

• Long ASML (12–24 months): buy equity or a calendar call spread (long-dated calls financed by shorter-dated calls) to capture capex-led order visibility. Target 30–50% upside if backlog converts; hard stop 12% below entry to protect against demand-shock rerates.
• Pair trade — Long AZN / Short NVDA (6–12 months): size to be cash-neutral to portfolio risk to harvest dividend / defensive carry while hedging AI-concentration beta. Target net return 10–15% if dispersion tightens; cap loss at 15% if NVDA continues accelerated rerating.
• Tactical relative play — Long SCHF / Short SPY (3–9 months): equal-dollar pair to express international multiple catch-up while neutralizing global beta. Overlay a 50% USD-forward hedge against the trade; take profits if relative outperformance >6% or cut at -5% within a month to avoid momentum reversal.
• FX-managed volatility sleeve: when initiating any international equity exposure, hedge 30–60% of local-currency risk with forwards or USD-call structures for a 6–12 month horizon. This reduces the largest single tail (currency) that can wipe out equity gains in a risk-off episode.